2020 Virtual ESMO Review
2020 ESMO Update on Advanced UC: Does the Addition of Avelumab 1L Maintenance to BSC in Advanced Disease Affect on Clinically Relevant PROs? Is There More PFS/OS Benefit Upon the Addition of Pembro to Chemo?
By
2020 Virtual ESMO Review
FEATURING
Manojkumar Bupathi
By
2020 Virtual ESMO Review
FEATURING
Manojkumar Bupathi
Login to view comments.
Click here to Login